Literature DB >> 8958309

Differential histochemical peanut agglutinin stain in benign and malignant human prostate tumors: relationship with prostatic specific antigen immunostain and nuclear DNA content.

T Janssen1, M Petein, R Van Velthoven, P Van Leer, M Fourmarier, J P Vanegas, A Danguy, C Schulman, J L Pasteels, R Kiss.   

Abstract

The histochemical binding pattern of the peanut (Arachis hypogaea) lectin (PNA) was quantitatively described by means of computer-assisted microscope analysis in 28 benign prostatic hyperplasias (BPH), 15 prostatic intraepithelial neoplasias (PIN), and 119 prostatic adenocarcinomas. PNA exhibits nonimmune but selective binding to glycoproteins with beta-D-galactosyl(1,3)-N-acetyl-D-galactosamine residues. We also investigated whether a relationship existed between the number of histochemical-related PNA acceptors and the histochemical prostate-specific antigen (PSA) stain intensity, and between the number of PNA receptors and DNA ploidy level. The results show that neoplastic prostate tissues and high-grade intraepithelial prostatic neoplasias (PIN2_3) exhibit a significantly higher number of PNA acceptors than benign prostatic hyperplasias and low (PIN1) grade prostatic intraepithelial neoplasias. A statistically significant correlation was observed between the number of histochemically related PNA acceptors and PSA immunostain intensity. Lastly, diploid prostatic tumors, whether benign or malignant, exhibited a significantly higher number of PNA acceptors than aneuploid ones. These results suggest that PNA acceptors play an important role in the biology of prostate tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958309     DOI: 10.1016/s0046-8177(96)90348-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Characterization of corpora amylacea glycoconjugates in normal and hyperplastic glands of human prostate.

Authors:  Eva Morales; Luis A Polo; Luis M Pastor; Luis Santamaría; Alfonso Calvo; Adelina Zuasti; Concepción Ferrer
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

2.  A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.

Authors:  M I Arenas; E Romo; I de Gaspar; F R de Bethencourt; M Sánchez-Chapado; B Fraile; R Paniagua
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

3.  Histochemical evaluation of human prostatic tissues with Cratylia mollis seed lectin.

Authors:  Amanda L R de Lima; Carmelita C B Cavalcanti; Mariana C C Silva; Patrícia M G Paiva; Luana C B B Coelho; Eduardo I C Beltrão; Maria T dos S Correia
Journal:  J Biomed Biotechnol       Date:  2010-06-16

Review 4.  The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.

Authors:  Lu-Gang Yu
Journal:  Glycoconj J       Date:  2007-04-25       Impact factor: 2.916

5.  Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.

Authors:  Swetha Tati; John C Fisk; Julia Abdullah; Loukia Karacosta; Taylor Chrisikos; Padraic Philbin; Susan Morey; Diala Ghazal; Fatma Zazala; Joseph Jessee; Sally Quataert; Stephen Koury; David Moreno; Jing Ying Eng; Vladislav V Glinsky; Olga V Glinskii; Muctarr Sesay; Anthony W Gebhard; Karamveer Birthare; James R Olson; Kate Rittenhouse-Olson
Journal:  Neoplasia       Date:  2017-08-19       Impact factor: 5.715

6.  A comparative study of recombinant and native frutalin binding to human prostate tissues.

Authors:  Carla Oliveira; José A Teixeira; Fernando Schmitt; Lucília Domingues
Journal:  BMC Biotechnol       Date:  2009-09-09       Impact factor: 2.563

7.  Bauhinia purprea agglutinin-modified liposomes for human prostate cancer treatment.

Authors:  Keisuke Ikemoto; Kosuke Shimizu; Kento Ohashi; Yoshihito Takeuchi; Motohiro Shimizu; Naoto Oku
Journal:  Cancer Sci       Date:  2015-12-11       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.